Robert Blelloch Named ISSCR's 2011 Outstanding Young Investigator  by Kriegstein, Arnold R.
Cell Stem Cell
ISSCR: Committee ForumRobert Blelloch Named ISSCR’s
2011 Outstanding Young InvestigatorRobert Blelloch from the University of California, San Francisco earned the 2011 ISSCR Outstanding Young
Investigator Award for his exceptional achievements as an early-career stem cell researcher.The International Society for Stem Cell Research (ISSCR) was
delighted to once again highlight the remarkable caliber of an
early-career stem cell biologist with the third annual ISSCR
Outstanding Young Investigator Award, supported by the
University of Pittsburgh. This year’s award went to Dr. Robert
Blelloch, an Associate Professor in the Departments of Urology;
Obstetrics, Gynecology, and Reproductive Sciences; and
Pathology at the University of California, San Francisco
(UCSF). He is a member of the Eli and Edythe Broad Center of
Regeneration Medicine and Stem Cell Research, the Center for
Reproductive Sciences, and the Helen Diller Cancer Center.
Since starting his own laboratory at UCSF in 2006, Robert has
distinguished himself as a leader in the small RNA and stem
cell fields.
Robert received combined M.D. and Ph.D. degrees from the
University of Wisconsin in 2001. During his Ph.D. he worked
under the mentorship of Dr. Judith Kimble, studying organogen-
esis in the nematode C. elegans. Using forward genetics,
molecular biology, and cell biology, he discovered a matrix met-
alloproteinase that is exquisitely regulated both spatially and
temporally in order to provide the distinct U-shaped tubes of
the C. elegans gonad. This groundbreaking work led to several
articles, including a cover story in Nature (Blelloch and Kimble,
1999). After completing his Ph.D., he returned to medical school,
where he was honored by selection to the Alpha Omega Alpha
Honor Medical Society and was chosen as the commencement
speaker for graduation ceremonies for all the graduate/profes-
sional students at the University of Wisconsin.
Following graduation, Robert moved to Boston to begin resi-
dency in Clinical Pathology at the Brigham and Women’s
Hospital, followed by fellowship training in Transfusion Medicine
in a combined Harvard Medical School program. It was during
his residency that he became interested in stem cells, largely
from his care of patients who were donating or receiving hema-
topoietic stem cells. In particular, he became fascinated with the
possible use of stem cells from other organs and even embryos
as potential therapeutics for a broad range of diseases. Robert
sought a postdoctoral research positionwith Dr. Rudolf Jaenisch
at the Whitehead Institute for Biomedical Research, who was
doing seminal work in reprogramming using somatic cell nuclear
transfer (SCNT). In the Jaenisch laboratory, Robert initially
collaborated with Dr. Konrad Hochedlinger, 2009 recipient of
the ISSCR Outstanding Young Investigator Award, using SCNT
to dissect the epigenetic versus genetic contribution to cancer
(Blelloch et al., 2004; Hochedlinger et al., 2004). Next, he
collaborated with Dr. Zhongde Wang to show how the state of
differentiation and DNA methylation can influence the efficiency
of dedifferentiation to embryonic stem cells following SCNT
(Blelloch et al., 2006).As an independent researcher, Robert has continued to follow
his interests in the molecular regulation of stem cell self-renewal,
differentiation, and dedifferentiation, and has already made
numerous seminal contributions. Early on, he developed a global
microRNA (miRNA) knockout model and uncovered critical roles
for miRNAs in cell cycle regulation and differentiation in embry-
onic stem cells (Wang et al., 2007). His laboratory went on to
explore in depth the mechanisms behind these observations
and has (1) defined a role for the ESCC family of miRNAs in
promoting the unique cell cycle structure of embryonic stem
cells by suppressing inhibitors of the G1/S transition (Wang
et al., 2008); (2) showed that this same family of miRNAs can
promote the dedifferentiation of somatic cells to induced plurip-
otent stem cells (Judson et al., 2009); (3) uncovered endoge-
nouos small interfering RNAs (endo-siRNAs) and noncanonical
miRNAs in mammals (Babiarz et al., 2008); (4) identified a role
for two opposing families of miRNAs in stabilizing the switch
between embryonic stem cell self-renewal and differentiation
(Melton et al., 2010); and (5) discovered that all miRNA function
is suppressed in the mammalian oocyte while endo-siRNA
function is essential for meiotic progression (Suh et al., 2010).
More recently, his laboratory has been looking at miRNAs as
a potential tool to systematically dissect the molecular pathways
that regulate cell fate transitions, including dedifferentiation of
somatic cells to induced pluripotent stem cells (Subramanyam
et al., 2011).
Robert has established a novel and independent line of
research providing profound insights into the posttranscriptional
regulation of early mammalian development. He has won severalCell Stem Cell 8, 631–632, June 3, 2011 ª2011 ISSCR 631
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ISSCR: Committee Forumawards since becoming a UCSF faculty member, including the
Pew Biomedical Sciences Scholarship and the National
Academy of Sciences Kavli Fellowship. Within UCSF, he is not
only a respected scientist but also a sought-after mentor and
teacher. Clearly, Robert has had a very substantial impact on
the stem cell field and the biological sciences in general, espe-
cially considering the early stage of his career, and it is highly
fitting that he should receive recognition through the 2011 ISSCR
Outstanding Young Investigator Award.
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